Zemplar (paricalcitol)
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Zemplar (paricalcitol), covering 2008-03-28 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer [Phase 2]